Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Eukaryotic translation initiation factor 4A1 (eIF4A1) is an **ATP-dependent RNA helicase** and a core component of the eIF4F translation initiation complex, which also includes eIF4E and eIF4G. eIF4A1 belongs to the **DEAD box helicase family**, distinguished by their conserved DEAD motif, and is primarily responsible for **unwinding secondary structures** in the 5'-untranslated region (UTR) of mRNAs, facilitating efficient ribosome loading and scanning to locate the start codon for translation[1][2][5][6]. eIF4A1 plays a central role in **cap-dependent translation initiation**. Its expression and function are regulated through interactions with co-factors such as eIF4G, eIF4B, and eIF4H, which enhance its helicase activity[2][4]. eIF4A1-mediated translation is crucial for cell growth and proliferation. Dysregulation or overactivity of eIF4A1 has been implicated in several **cancers**, including acute myeloid leukemia and other hematologic malignancies, by promoting translation of oncogenic mRNAs with complex 5’-UTRs[3]. eIF4A1 is thus considered a viable **anticancer therapeutic target**, with several experimental inhibitors under investigation.
Inhibition of ATP-dependent RNA helicase activity, impeding mRNA unwinding necessary for translation initiation—targeting eIF4A1 blocks assembly of the eIF4F complex and translation of oncogenic mRNAs
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Eukaryotic translation initiation factor 4A1 (eIF4A1).